The Lancet Gastroenterology & Hepatology 9(2): 159 [PubMed] Tong J, Lan XT, Zhang Z, Liu Y, Sun DY, Wang XJ, Ou-Yang SX, Zhuang CL, Shen FM, Wang P, Li DJ (2023) Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis
Heres what to watch as this $40B+ category continues to grow
Gigascience 10 , giab008 (2021)
The study found that in patients with atrial fibrillation (AF) and obesity, an association existed between the use of GLP-1s and a 13% reduction in major AF-related events, including cardioversions, hospitalizations, and ablation procedures
Real-world considerations and what providers say Theory is one thing
This is exactly where the right supplements can make a significant difference